Inspyr Therapeutics and Lewis and Clark Pharmaceuticals Complete Merger
Clark Pharmaceuticals | September 13, 2017
Inspyr Therapeutics, a clinical-stage biotechnology company, and Lewis and Clark Pharmaceuticals today announced the successful completion of a merger to create an integrated biotechnology company. The newly combined company creates a second proprietary technology platform, broad capability laboratory facilities, pipeline of therapeutics, and drug development expertise to create value across the business.